丽珠医药(01513)9月16日斥资369.14万元回购9.21万股A股

Core Viewpoint - Lijun Pharmaceutical (01513) announced a share buyback plan, intending to repurchase 92,100 A-shares at a cost of 3.6914 million yuan by September 16, 2025 [1] Company Summary - The company plans to spend 3.6914 million yuan for the buyback [1] - The total number of shares to be repurchased is 92,100 A-shares [1]